X0RnJBhvGOmX0r4InAw5F0pl-yWCI-9AZDLEiu6bep0

NEWS & INFORMATION: Mental Health and Drug Addiction

MORE INFORMATION & NEWS ON ADDICTION AND MENTAL HEALTH ISSUES…

At Illuminate Recovery and Wellness Centers we greatly value the importance on information sharing when it comes to matters of substance abuse and other addictions, as well as mental health disorders in general. Whether you’re doing research prior to choosing the right inpatient drug or alcohol rehab center, sober living home, therapist, etc., or even searching for reference material for a college term paper, you can never have too much practical information. Fortunately, with today’s technology and steady flow of emerging data throughout the web, we are able to merge our own information (upper portion of the page) with an embedded news feed (lower portion of the page) taken directly from NIDA (National Institute on Drug Abuse).

The links directly below will take you to a series of articles published by us, all of which relate to matters surrounding substance abuse & addictions, mental health and dual-diagnosis disorders. While the information provided below is NOT intended to officially diagnose any disease or illness, it has been published as accurately as possible.

 


Latest news & information on addiction and mental health from NIDA:

  • Project to deter opioid tampering wins 2019 NIDA Addiction Science Award May 17, 2019
    A 14-year-old’s innovative approach to prevent tampering and misuse of opioid pills won a first place Addiction Science Award at the 2019 Intel International Science and Engineering Fair (ISEF)—the world’s largest science competition for high school students. The awards are...
  • National Institute on Drug Abuse Intramural Research Program Holds Opioid Symposium May 15, 2019
    The National Institute on Drug Abuse (NIDA) Intramural Research Program will hold a one-day symposium to summarize the most recent advances in opioid research. Topics range from the use of a therapeutic workplace to address opioid use disorders to basic research such as findings...
  • Opioid Dose Variability Associated with Overdose April 22, 2019
    Photo by ©iStock.com/dptulk As health care providers lower opioid doses for pain patients to minimize the risk of addiction; increase doses to manage worsening pain; or re-start dosing after a period of time without opioid pain relievers, patients could be getting confused about safe...
  • Opioids without the risk of addiction? March 26, 2019
    Scientists are working to develop medicines that have the pain-relieving effects of opioids without the high risk of misuse and addiction. Since misuse is linked to the euphoric effects of the drug, investigators led by scientists at NIDA’s intramural labs are studying methadone, a drug...
  • Dr. Jack Stein appointed NIDA Chief of Staff March 20, 2019
    Jack B. Stein, Ph.D. Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), has appointed Jack B. Stein, Ph.D., to be the NIDA Chief of Staff, a newly created position to support and assist the Director with coordination and strategic planning of key institute initiatives....
  • Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray March 15, 2019
    Naloxone is a potentially life-saving drug commonly used to reverse opioid overdoses and can be injected as a liquid or delivered as a nasal spray. The fastest method of delivery is through an intravenous (IV) dose, but many first responders, police, families or friends are not well equipped...
  • Serotonin Unexpectedly Regulates Expression of Brain Genes March 13, 2019
    The brain chemical serotonin can regulate expression of genes within neurons in a very unexpected way, as described in a NIDA-funded paper just published in the journal Nature. It is all part of the marvel of DNA and how it works to form our individual biological maps. The mechanism...
  • Monthly buprenorphine injections effective for opioid use disorders February 19, 2019
    A newly published study suggests the long-acting buprenorphine formulation BUP-XR is more effective than placebo in helping patients struggling with addiction to opioids. BUP-XR is a monthly extended-release injection. Source: Photo by ©iStock.com/ognianm Daily dose buprenorphine was...
  • New toolkit for genomic editing holds promise for addiction research February 19, 2019
    The scientific world has advanced immeasurably by the science of DNA and genetics. Manipulating gene expression to change the way that cells such as neurons function has helped scientists create very specific tools to use for understanding and developing treatments for human diseases. For human...
  • Higher rates of NAS linked with economic conditions January 29, 2019
    ©iStock/brebca A NIDA-funded analysis of eight states showed a significant association between rates of neonatal abstinence syndrome (NAS) and poor economic conditions. NAS is a series of uncomfortable symptoms experienced by newborns suffering from opioid withdrawal after their mothers...

HOUSTON  ADDICTION  RECOVERY  CENTERS


Here for you 24/7

 


833-400-0170